69: Outcomes with nintedanib and docetaxel in patients with relapsed NSCLC adenocarcinoma treated within the UK Nintedanib Individual Patient Supply programme.
Resource Type
Article
Authors
Tokaca, N. ; Crawford, M.S. ; Greystoke, A. ; Appel, W. ; Lal, R. ; Steele, N. ; Ali, C. ; Bezecny, P. ; Fernando, S. ; Karapanagiotou, E. ; Skailes, G. ; Dorey, N. ; Harrow, S. ; Bhosle, J. ; Khan, O. ; Newsom-Davis, T. ; Spicer, J. ; Toy, L. ; O'Brien, M. ; Gunapala, R.
Source
Lung Cancer (01695002) . Jan2017 Supplement 1, Vol. 103, pS32-S33. 1p.
Subject
*NON-small-cell lung carcinoma *DOCETAXEL *CANCER treatment *ADENOCARCINOMA *HEALTH programs *PATIENTS
Language
ISSN
0169-5002